Abstract: The present invention provides a mid-gingival dental implant system that includes a dental implant having a threaded body portion and a superstructure extending from a coronal surface of the threaded body portion. The superstructure includes two O-ring housings for housing deformable O-rings. The mid-gingival system can also include two screws. One for screw retained final components and one for cement retained final components.

Abstract: A dental implant and a dental implant assembly comprises a dental implant having a longitudinal-axial-pre-load. The dental implant has an insert portion, and an outer shell portion. The insert portion of the implant is affixed within a longitudinal-axial opening of the outer shell portion of the implant. The affixation of the inner portion within the axial opening of the outer shell portion of the implant applies a pre-load in a longitudinal axial direction on the implant. The dental implant assembly further comprises an abutment and a retaining screw. The abutment is adapted to be attached to the dental implant. The retaining screw is adapted fasten the abutment to the dental implant.

Abstract: In accordance with the present invention, a method and device is provided for administering therapeutically effective doses of the drug azospirone transdermally for treating psychogenic symptomatologies. One embodiment of the present invention comprises an effective amount of solubilized azospirone in a transdermal drug delivery device. By practicing the present invention, constant blood concentrations of azospirone can be maintained over a prolonged period of time, side effects can be minimized with maximal patient compliance.

Abstract: In accordance with the present invention, a method and device is provided for administering therapeutically effective doses of the drug azospirone transdermally for treating psychogenic symptomatologies. One embodiment of the present invention comprises an effective amount of solubilized azospirone in a transdermal drug delivery device. By practicing the present invention, constant blood concentrations of azospirone can be maintained over a prolonged period of time, side effects can be minimized with maximal patient compliance.

Abstract: In accordance with the present invention, a method and device is provided for administering therapeutically effective doses of the drug azospirone transdermally for treating psychogenic symptomatologies. One embodiment of the present invention comprises an effective amount of solubilized azospirone in a transdermal drug delivery device. By practicing the present invention, constant blood concentrations of azospirone can be maintained over a prolonged period of time, side effects can be minimized with maximal patient compliance.